Ignite Creation Date:
2024-05-06 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 2:27 PM
Study NCT ID:
NCT05277571
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2022-03-03
Brief Title:
A Single-ascending Dose Part A and Repeat-dose Part B Study to Investigate the Safety Pharmacokinetics and Efficacy Part B Only of UCB1381 in Healthy Study Participants Part A and in Study Participants With Moderate to Severe Atopic Dermatitis Part B
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Organization Data
Organization:
UCB Pharma
Class:
INDUSTRY
Study ID:
UP0110
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UCB Biopharma SRL
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None